ENPHENOMENAL
LIVE

Serial Number

79440931

Owner

Regeron, Inc.

Attorney

Leigh Ann Lindquist

Filing Date

Sep 9, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ENPHENOMENAL Trademark

Serial Number: 79440931

ENPHENOMENAL is a trademark filed by Regeron, Inc. on September 9, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Regeron, Inc. (17 trademarks)

103 Bio-2 Hi-Tech Venture Town
Chuncheon, Kangwon-Do 200-161 , KR

Entity Type: 03

Trademark Details

Filing Date

September 9, 2025

Registration Date

Not Registered

Published for Opposition

October 20, 2026

Goods & Services

Nutraceuticals containing whey protein and coconut fiber for use as a dietary supplement; nutritional supplements containing whey protein and coconut fiber; nutritional supplements for medical use; dietary and nutritional supplements for gut health and muscle strengthening; micro-nutrient supplements; nutraceuticals for use as dietary supplements; dietary supplements consisting of amino acid; mineral supplements; nutraceuticals for therapeutic or medical use for the treatment of obesity, diabetes, sleep disorders; food supplements, namely, anti-oxidants

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 30, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 30, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 20, 2026 TROA
REFUSAL PROCESSED BY IB
Mar 19, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 5, 2026 RFCS
REFUSAL PROCESSED BY MPU
Mar 5, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 4, 2026 RFCR
NON-FINAL ACTION WRITTEN
Feb 3, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 22, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 8, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 8, 2026 REPR